[
  {
    "ts": null,
    "headline": "Should Value Investors Buy Becton, Dickinson and Company (BDX) Stock?",
    "summary": "Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.",
    "url": "https://finnhub.io/api/news?id=02fc84880538ab95b45ba8f337faf4a16c30a425f921995adf107f5e8a0800f1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758120004,
      "headline": "Should Value Investors Buy Becton, Dickinson and Company (BDX) Stock?",
      "id": 136789997,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BDX",
      "source": "Yahoo",
      "summary": "Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.",
      "url": "https://finnhub.io/api/news?id=02fc84880538ab95b45ba8f337faf4a16c30a425f921995adf107f5e8a0800f1"
    }
  },
  {
    "ts": null,
    "headline": "BD Marks 1,000th BD Rhapsody System, Driving Scientific Breakthroughs via Single-Cell Multiomics",
    "summary": "BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced the placement of the 1,000th BD Rhapsody™ System, a flagship instrument for single-cell multiomics analysis, at Addenbrooke's Hospital of the University of Cambridge, United Kingdom. Together with its comprehensive menu of assays for DNA, RNA, and protein analysis, the instrument enables scientists to capture deeper insights from hundreds of thousands of single cells at a time.",
    "url": "https://finnhub.io/api/news?id=51a07234d04ff3442bc6e46a12e6699190dcf0ff2c6a0ba066653efabe4cc66a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758109800,
      "headline": "BD Marks 1,000th BD Rhapsody System, Driving Scientific Breakthroughs via Single-Cell Multiomics",
      "id": 136787688,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BDX",
      "source": "Yahoo",
      "summary": "BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced the placement of the 1,000th BD Rhapsody™ System, a flagship instrument for single-cell multiomics analysis, at Addenbrooke's Hospital of the University of Cambridge, United Kingdom. Together with its comprehensive menu of assays for DNA, RNA, and protein analysis, the instrument enables scientists to capture deeper insights from hundreds of thousands of single cells at a time.",
      "url": "https://finnhub.io/api/news?id=51a07234d04ff3442bc6e46a12e6699190dcf0ff2c6a0ba066653efabe4cc66a"
    }
  },
  {
    "ts": null,
    "headline": "Celltrion Pharm Signs Strategic Trilateral Agreement with Becton Dickinson and BD Korea to Accelerate Global PFS CMO Business",
    "summary": "CHEONGJU, South Korea, September 17, 2025--Celltrion Pharm signed a trilateral agreement with Becton Dickinson France and BD Korea, combining its CMO capabilities with BD’s customer network.",
    "url": "https://finnhub.io/api/news?id=0c442783d8f290effbe1f4a9fa3f0ad9f223fc9c66f99795301d708aa2ad3ce4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758070800,
      "headline": "Celltrion Pharm Signs Strategic Trilateral Agreement with Becton Dickinson and BD Korea to Accelerate Global PFS CMO Business",
      "id": 136787689,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BDX",
      "source": "Yahoo",
      "summary": "CHEONGJU, South Korea, September 17, 2025--Celltrion Pharm signed a trilateral agreement with Becton Dickinson France and BD Korea, combining its CMO capabilities with BD’s customer network.",
      "url": "https://finnhub.io/api/news?id=0c442783d8f290effbe1f4a9fa3f0ad9f223fc9c66f99795301d708aa2ad3ce4"
    }
  }
]